Paradigm Biocapital Advisors LP

13F Holdings History for UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)

Symbol: URGN on Nasdaq
Investment type: Equity / Ordinary Shares, par value NIS 0.01 per share
Latest Disclosed Ownership: 4.22M shares
Security Ownership: 9%

Shares, Excluding Options vs Price

Value, Excluding Options

Paradigm BioCapital Advisors LP ownership in UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN)

2025-11-14 - Paradigm BioCapital Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.22M shares of UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN). This represents 9% percent ownership of the company. In their previous filing dated 2025-08-12, Paradigm Biocapital Advisors LP had reported owning 2.33M shares, indicating an increase of 80.8% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Paradigm BioCapital Advisors LP	9%	+80%	$84.1M	4.22M	+1,884,018	+80.8%	$19.95	13G/A	9/30/2025	14 Nov 2025 16:31:47
Paradigm BioCapital Advisors LP	5%		$31.9M	2.33M			$13.70	13G	8/5/2025	12 Aug 2025 16:30:35

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025		2.49%	+2.49%	$84.1M	4.22M	+4,216,084	NEW	$19.95	Q3 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.